Wealth Mantra Official ️
1.37K subscribers
48.7K photos
22 videos
3.24K files
2.02K links
✌️Suggestions on Strong Fundamental Companies & Technical Analysis + COMPANY NEWS & RESULTS + epaper + CONCALLS🍀

We are not SEBI registered.The information provided is for educational purposes only. We will not be responsible for any of your profit/loss
Download Telegram
CELLECOR GADGETS: CO HAS SIGNED A STRATEGIC NON-DISCLOSURE AGREEMENT (NDA) WITH SHENZHEN H&T INTELLIGENT CONTROL CO || THE PROPOSED FACILITY WILL SPECIALIZE IN INTELLIGENT CONTROLLERS, SENSORS, CHIPS, SEMICONDUCTOR COMPONENTS, AND INTEGRATED SMART SOLUTIONS
Csb Bank Q4:

CSB Bank reports #Q4 earnings

Net Profit Up 25.7% at ₹190.4 Cr Vs ₹151.5 Cr (YoY)

NII Down 3.8% at ₹371.3 Cr Vs ₹386.1 Cr (YoY)

Net NPA at 0.52% Vs 0.64% (QoQ)

Gross NPA at 1.57% Vs 1.58% (QoQ)

Q4 Sl Net Profit 1.9b Rupees Vs 1.5b (YoY)

Q4 GNPA 1.57% Vs 1.58% (QoQ)

Q4 NNPA 0.52% Vs 0.64% (QoQ)

Q4 Interest Earned 9.8b Rupees Vs 7.94b (YoY)

Join us @wealthmantraofficial
Insurance Cos in Focus

DFS Secretary assures life insurance industry on ‘no action’ against bancassurance channel

DFS: Department of Financial Services

DFS Secretary acknowledges importance of bancassurance channel for life insurance companies

DFS Secretary asks life insurers to ensure that complains of mis-selling do not rise & bancassurance channel expands3

Join us @wealthmantraofficial
AB SUNLIFE AMC Q4

NET PROFIT AT 228 CR V 224 CR QOQ

REVENUE AT 427 CR V 445 CR QOQ

EBITDA AT 243 CR V 274 CR QOQ

MARGINS AT 56.8 % V 61.6 % QOQ

Join us @wealthmantraofficial
Nifty snaps 2-session losing streak; RIL, Sun Pharma lead!
Here's how the markets panned out today!
#JustIn | Kirloskar Electric appoints Meena Kirloskar as Vice Chairperson of the company with immediate effect
TVS Motor delivered a very strong Q4 performance :- 📈

TVSMOTOR- 2,822.60 📈84.70 (3.09%)

Q4 SL NET PROFIT 8.5B RUPEES VS 4.85B (YOY); EST 7.71B

Q4 EBITDA 13.3B RUPEES VS 9.26B (YOY); EST 12.49B

Q4 EBITDA MARGIN 13.96% VS 11.34% (YOY); EST 13.3%

🔖EBITDA rose to 13.3 billion INR (from 9.26 billion last year), beating the 12.49 billion estimate.

🔖EBITDA margin improved to 13.96% (vs. 11.34% last year), ahead of the 13.3% forecast.

🔖Net profit jumped to 8.5 billion INR (up from 4.85 billion), above the 7.71 billion estimate.

🔖Overall, TVS Motor not only grew sharply year-over-year but also exceeded market expectations across all key metrics.

Join us @wealthmantraofficial
TVS Motor reports Q4 earnings

Net Profit at ₹852 cr vs CNBC-TV18 poll of ₹771 cr
TVS Motor reports Q4 earnings

Revenue at ₹9,550 cr vs CNBC-TV18 poll of ₹9,394 cr
TVS Motor reports #Q4 earnings

Profit at ₹852 cr vs ₹485 cr (YoY)

Join us @wealthmantraofficial
📊 Central Bank of India || Q4 FY25 Results

➡️ Revenue from Operations
₹10,476.05 crore (QoQ: +7.18%, YoY: +7.69%)

➡️ Profit Before Tax (PBT)
₹1,170.58 crore (QoQ: -17.77%, YoY: +44.26%)

➡️ Net Profit (PAT)
₹1,104.58 crore (QoQ: +14.66%, YoY: +36.36%)

➡️ Earnings Per Share (EPS)
₹1.27 (QoQ: +14.41%, YoY: +35.11%)

🔹 Overall Verdict: Good
➤ Strong YoY momentum in revenue and profits; QoQ PBT decline due to higher provisions.

🔍 What the Numbers Say
🔹 Revenue Performance
➤ Interest income growth from advances led to revenue uptick; healthy disbursements seen in Q4.

🔹 Profitability Insights
➤ Despite higher provisions, net profit rose on better operating efficiencies and lower tax outgo.

🔹 Cost & Efficiency
➤ Operating expenses under control; employee cost rose marginally. Cost-to-income ratio stable.

Join us @wealthmantraofficial
Castrol India reports Q4 earnings:

Net Profit Up 8% at ₹234 Cr Vs ₹216 Cr (YoY)

Revenue Up 7.3% at ₹1,422 Cr Vs ₹1,325 Cr (YoY)

EBITDA Up 4.7% at ₹308 Cr Vs ₹294 Cr (YoY)

Margin at 21.6% Vs 22.2% (YoY)

Join us @wealthmantraofficial
#BreakingNews | March IIP at 3% vs 2.7% (MoM)
#BreakingNews | Mining growth at 0.4% vs 1.6% (MoM)

Manufacturing growth at 3% vs 2.8% (MoM)

Electricity growth at 6.3% vs 3.6% (MoM)
🚀 Wipro & Vorwerk Partner for IT Transformation: A 5-Year AI-Powered Engagement | MCap 2,52,176.44 Cr

- Wipro wins 5-year IT transformation engagement with Vorwerk, a top European direct sales company.
- AI-powered infrastructure solutions will streamline Vorwerk’s IT operations, cybersecurity, and app consolidation.
- Unified monitoring platform to enhance operational efficiency and risk management.
- Collaboration with Vorwerk’s tech partners to standardize products and accelerate time-to-market.
- End-to-end support portal to improve user experience.
- Vorwerk operates in 61+ countries with €3.2B in 2023 sales; Wipro has 230,000+ employees across 65 countries.
- Vorwerk’s Group CIO praises Wipro’s alignment with their quality and sustainability goals.
- Wipro’s regional lead highlights strategic value of the partnership in Germany and Austria.

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.
Vimta Labs Reports Strong FY25 Growth 📈
Revenue Up 19.1%, PAT Jumps 36.8%
| MCap 2,270.37 Cr

- Added ~200,000 sft of modern lab space at Life Sciences Facility
- Secured regulatory approvals from USFDA, European Medicines Agency, Turkey, Kazakhstan, NGCMA, and CDSCO
- CRL division successfully transferred to Thyrocare
- EMTAC merger with Vimta approved by NCLT Hyderabad
- Food Division won CII's 'Outstanding Laboratory Performance Award 2024' (2nd consecutive year)
- Relocated Pune food lab to Nashik for better agri-produce access
- Q4 FY25 revenue: ₹944.4 Mn (+31.4% YoY)
- FY25 total income: ₹3,482.2 Mn (+19.1% YoY)
- Q4 EBIDTA: ₹346.8 Mn (+31.9% YoY) | Margin: 36.1%
- FY25 EBIDTA: ₹1,261.9 Mn (+29.1% YoY) | Margin: 36.2%
- FY25 PAT: ₹667.5 Mn (+36.8% YoY) | Margin: 19.2%
- Basic EPS: ₹30.0 (+36.2% from ₹22.0 in FY24)
- Market cap: ₹2,223.67 Cr | Free float: 63.30%
- Strong balance sheet: ₹85 Mn debt vs ₹329 Mn cash
- Operates in drug discovery, food/agri, electronics & environment testing
- Labs across 9 Indian cities
- Leadership: Dr. S P Vasireddi (Chairman), Harita Vasireddi (MD), Sreenivas Neerukonda (ED)
DOLPHIN OFFSHORE Q4

NET PROFIT AT 10.44 CR V 15.5 CR QOQ

REVENUE AT 20.44 CR V 28.5 CR QOQ

EBITDA AT 11.33 CR VS 15.70 CR QOQ

MARGINS 55.43% VS 55.11% QOQ

Join us @wealthmantraofficial
Wealth Mantra Official ️
Vimta Labs Reports Strong FY25 Growth 📈 Revenue Up 19.1%, PAT Jumps 36.8% | MCap 2,270.37 Cr - Added ~200,000 sft of modern lab space at Life Sciences Facility - Secured regulatory approvals from USFDA, European Medicines Agency, Turkey, Kazakhstan, NGCMA…
VIMTA LAB Q4FY25 CONS.

PAT ⬇️ 14.8% at ₹18.32 Cr (QOQ), 🔼 48.4% (YOY)

REVENUE ⬇️ 5.0% at ₹96.08 Cr (QOQ), 🔼 32.1% (YOY)

EBITDA ⬇️ 10.3% at ₹26.77 Cr (QOQ), 🔼 41.7% (YOY)

EBITDA MARGINS 27.9% vs 30.0% (QOQ), 27.0% (YOY)

Join us @wealthmantraofficial